Works matching IS 01615505 AND DT 2023 AND VI 64
Results: 351
Somatostatin Receptor Antagonists as a Theranostic Option in Iodine-Refractory Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 2001, doi. 10.2967/jnumed.123.265639
- By:
- Publication type:
- Article
Theranostics Is Not Radiotheranostics.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 2002, doi. 10.2967/jnumed.123.266491
- By:
- Publication type:
- Article
Theranostics Is Not Radiotheranostics.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 2002, doi. 10.2967/jnumed.123.266292
- By:
- Publication type:
- Article
One Hundred Years of the Tracer Principle.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1998, doi. 10.2967/jnumed.123.266458
- By:
- Publication type:
- Article
Performance Characteristics of a New-Generation Digital Bismuth Germanium Oxide PET/CT System, Omni Legend 32, According to NEMA NU 2-2018 Standards.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1990, doi. 10.2967/jnumed.123.266140
- By:
- Publication type:
- Article
[<sup>18</sup>F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1980, doi. 10.2967/jnumed.123.265856
- By:
- Publication type:
- Article
Clinical Characterization of [<sup>18</sup>F]T-008, a Cholesterol 24-Hydroxylase PET Ligand: Dosimetry, Kinetic Modeling, Variability, and Soticlestat Occupancy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1972, doi. 10.2967/jnumed.123.265912
- By:
- Publication type:
- Article
<sup>177</sup>Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior <sup>223</sup>Ra (RALU Study).
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1925, doi. 10.2967/jnumed.123.266125
- By:
- Publication type:
- Article
[<sup>123</sup>I]CC1: A PARP-Targeting, Auger Electron--Emitting Radiopharmaceutical for Radionuclide Therapy of Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1965, doi. 10.2967/jnumed.123.265429
- By:
- Publication type:
- Article
Immuno-PET and Targeted a-Therapy Using Anti--Glypican-1 Antibody Labeled with <sup>89</sup>Zr or <sup>211</sup>At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1949, doi. 10.2967/jnumed.123.266313
- By:
- Publication type:
- Article
Preclinical Evaluation of a Radiotheranostic Single-Domain Antibody Against Fibroblast Activation Protein α.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1941, doi. 10.2967/jnumed.123.266381
- By:
- Publication type:
- Article
Tumor-Targeted Interleukin 2 Boosts the Anticancer Activity of FAP-Directed Radioligand Therapeutics.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1934, doi. 10.2967/jnumed.123.266007
- By:
- Publication type:
- Article
Sequential and Combination Therapies of <sup>223</sup>RaCl<sub>2</sub> and Prostate-Specific Membrane Antigen Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1932, doi. 10.2967/jnumed.123.266427
- By:
- Publication type:
- Article
Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1956, doi. 10.2967/jnumed.123.265418
- By:
- Publication type:
- Article
An Intrapatient Dosimetry Comparison of <sup>177</sup>Lu-rhPSMA-10.1 and <sup>177</sup>Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1918, doi. 10.2967/jnumed.123.265970
- By:
- Publication type:
- Article
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor (<sup>68</sup>Ga-FAPI) PET for Pancreatic Adenocarcinoma: Data from the 68Ga-FAPI PET Observational Trial.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1910, doi. 10.2967/jnumed.122.264827
- By:
- Publication type:
- Article
Oncologic Staging with <sup>68</sup>Ga-FAPI PET/CT Demonstrates a Lower Rate of Nonspecific Lymph Node Findings Than <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1906, doi. 10.2967/jnumed.123.265751
- By:
- Publication type:
- Article
<sup>68</sup>Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT for the Early and Late Prediction of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer Patients: A Prospective Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1899, doi. 10.2967/jnumed.123.266079
- By:
- Publication type:
- Article
Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1895, doi. 10.2967/jnumed.123.266185
- By:
- Publication type:
- Article
Imaging Agents for PET of Inflammatory Bowel Disease: A Review.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1858, doi. 10.2967/jnumed.123.265935
- By:
- Publication type:
- Article
First-in-Humans PET Imaging of KRAS<sup>G12C</sup> Mutation Status in Non--Small Cell Lung and Colorectal Cancer Patients Using [<sup>18</sup>F]PFPMD.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1880, doi. 10.2967/jnumed.123.265715
- By:
- Publication type:
- Article
ChatGPT: Can You Prepare My Patients for [<sup>18</sup>F]FDG PET/CT and Explain My Reports?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1876, doi. 10.2967/jnumed.123.266114
- By:
- Publication type:
- Article
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1869, doi. 10.2967/jnumed.123.265874
- By:
- Publication type:
- Article
Molecular Markers Are Associated with Onset of Radioiodine Refractoriness in Patients with Papillary Thyroid Carcinoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1865, doi. 10.2967/jnumed.123.266044
- By:
- Publication type:
- Article
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1889, doi. 10.2967/jnumed.123.266074
- By:
- Publication type:
- Article
<sup>61</sup>Cu-Labeled Radiotracers: Alternative or Choice?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1855, doi. 10.2967/jnumed.123.266171
- By:
- Publication type:
- Article
Ethical Considerations for Artificial Intelligence in Medical Imaging: Data Collection, Development, and Evaluation.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1848, doi. 10.2967/jnumed.123.266080
- By:
- Publication type:
- Article
The Hierarchy of SUVs: From Diagnostics to Therapeutics and the Pathway to Effective Theranostics.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1845, doi. 10.2967/jnumed.123.266930
- By:
- Publication type:
- Article
A Strategic Approach to Advancing Nuclear Medicine and Molecular Imaging.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1843
- By:
- Publication type:
- Article
The Evolution of Cardiac Nuclear Imaging.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 1S, doi. 10.2967/jnumed.123.266845
- By:
- Publication type:
- Article
Quantitative Perfusion Imaging with Total-Body PET.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 11S, doi. 10.2967/jnumed.122.264870
- By:
- Publication type:
- Article
Infection Imaging: Focus on New Tracers?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 59S, doi. 10.2967/jnumed.122.264869
- By:
- Publication type:
- Article
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 29S, doi. 10.2967/jnumed.122.264868
- By:
- Publication type:
- Article
Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 49S, doi. 10.2967/jnumed.122.264867
- By:
- Publication type:
- Article
Molecular Imaging of Systemic and Cardiac Amyloidosis: Recent Advances and Focus on the Future.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 20S, doi. 10.2967/jnumed.122.264866
- By:
- Publication type:
- Article
Imaging Inflammation Past, Present, and Future: Focus on Cardioimmunology.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 39S, doi. 10.2967/jnumed.122.264865
- By:
- Publication type:
- Article
Future of Radionuclide Myocardial Perfusion Imaging: Transitioning from SPECT to PET.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, p. 3S, doi. 10.2967/jnumed.122.264864
- By:
- Publication type:
- Article
HER2-Low Breast Cancer Can Be Visualized by HER2 PET.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1841, doi. 10.2967/jnumed.123.266101
- By:
- Publication type:
- Article
REPLY.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1841, doi. 10.2967/jnumed.123.266490
- By:
- Publication type:
- Article
Obstructive Sialadenitis from Oral Squamous Cell Carcinoma: [<sup>68</sup>Ga]Ga-FAPI-46 PET-Positive and [<sup>18</sup>F]FDG PET-Negative.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1839, doi. 10.2967/jnumed.123.265498
- By:
- Publication type:
- Article
Total-Body Perfusion Imaging with [<sup>11</sup>C]-Butanol.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1831, doi. 10.2967/jnumed.123.265659
- By:
- Publication type:
- Article
Total-Body Multiparametric PET Quantification of <sup>18</sup>F-FDG Delivery and Metabolism in the Study of Coronavirus Disease 2019 Recovery.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1821, doi. 10.2967/jnumed.123.265723
- By:
- Publication type:
- Article
Long Versus Short Axial Field of View Immuno-PET/CT: Semiquantitative Evaluation for <sup>89</sup>Zr-Trastuzumab.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1815, doi. 10.2967/jnumed.123.265621
- By:
- Publication type:
- Article
Detection of IL12/23p40 via PET Visualizes Inflammatory Bowel Disease.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1806, doi. 10.2967/jnumed.123.265649
- By:
- Publication type:
- Article
Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1798, doi. 10.2967/jnumed.123.265941
- By:
- Publication type:
- Article
Optimized Methods for the Production of High-Purity <sup>203</sup>Pb Using Electroplated Thallium Targets.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1791, doi. 10.2967/jnumed.123.265976
- By:
- Publication type:
- Article
Second Symposium of the European Working Group on the Radiobiology of Molecular Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1788, doi. 10.2967/jnumed.123.265956
- By:
- Publication type:
- Article
Lesion Dosimetry for [<sup>177</sup>Lu]Lu-PSMA-617 Radiopharmaceutical Therapy Combined with Stereotactic Body Radiotherapy in Patients with Oligometastatic Castration-Sensitive Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1779, doi. 10.2967/jnumed.123.265763
- By:
- Publication type:
- Article
Tandem Isotope Therapy with <sup>225</sup>Ac- and <sup>177</sup>Lu-PSMA-617 in a Murine Model of Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1772, doi. 10.2967/jnumed.123.265433
- By:
- Publication type:
- Article
Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of <sup>177</sup>Lu-PSMA I&T.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 11, p. 1765, doi. 10.2967/jnumed.123.265878
- By:
- Publication type:
- Article